| answer text |
<p>The Government has now accepted the recommendations from the independent Medicines
and Healthcare products Regulatory Agency (MHRA) to authorise three COVID-19 vaccines
for use from Pfizer/BioNTech, Oxford University/AstraZeneca, and Moderna. This follows
months of rigorous clinical trials and a thorough analysis of the data by experts
at the MHRA who have concluded that all three vaccines met its strict standards of
safety, quality, and effectiveness.</p><p> </p><p>The Joint Committee on Vaccination
and Immunisation (JCVI) are the independent experts who advise the Government on which
vaccine/s the United Kingdom should use and provide advice on prioritisation at a
population level. For the first phase, the JVCI has advised that the vaccine be given
to care home residents and staff, as well as frontline health and social care workers,
then to the rest of the population in order of age and clinical risk factors. Included
in this are those with underlying health conditions, which put them at higher risk
of serious disease and mortality.</p>
|
|
